(Q40944878)

25 September 2017

Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin (English)

1 reference

25 September 2017

0 references

Pseudomonas aeruginosa

1 reference

Anderson EL

1

1 reference

25 September 2017

Gramling PK

series ordinal

2

1 reference

25 September 2017

Vestal PR

series ordinal

3

1 reference

25 September 2017

Farrar WE Jr

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1975

1 reference

Antimicrobial Agents and Chemotherapy

25 September 2017

1 reference

25 September 2017

8

1 reference

25 September 2017

3

1 reference

25 September 2017

300-304

1 reference

Tobramycin (Nebramycin Factor 6): In Vitro Activity Against Pseudomonas aeruginosa

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

In Vitro Susceptibility of Pseudomonas aeruginosa to Carbenicillin and the Combination of Carbenicillin and Gentamicin

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

The Use of Combinations of Antimicrobial Drugs

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Clinical Study of the Use of the New Aminoglycoside Tobramycin for Therapy of Infections Due to Gram-Negative Bacteria

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Carbenicillin: activity in vitro and absorption and excretion in normal young men.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Synergism of Carbenicillin and Gentamicin Against Enterococci

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

In vitro activity of tobramycin and gentamicin

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Tobramycin: In Vitro Antibacterial Spectrum of a New Aminoglycoside

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429310

Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/810083

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative pharmacokinetics of tobramycin and gentamicin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/810083

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.8.3.300

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

810083

1 reference